• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一系列选择性 G 蛋白抑制剂的全合成及构效关系研究。

Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.

机构信息

Department of Drug Design and Pharmacology, University of Copenhagen, DK-2100 Copenhagen, Denmark.

Endocrine Unit, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114, USA.

出版信息

Nat Chem. 2016 Nov;8(11):1035-1041. doi: 10.1038/nchem.2577. Epub 2016 Jul 25.

DOI:10.1038/nchem.2577
PMID:27768111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5559716/
Abstract

G proteins are key mediators of G protein-coupled receptor signalling, which facilitates a plethora of important physiological processes. The cyclic depsipeptides YM-254890 and FR900359 are the only known specific inhibitors of the G subfamily of G proteins; however, no synthetic route has been reported previously for these complex natural products and they are not easily isolated from natural sources. Here we report the first total synthesis of YM-254890 and FR900359, as well as of two known analogues, YM-385780 and YM-385781. The versatility of the synthetic approach also enabled the design and synthesis of ten analogues, which provided the first structure-activity relationship study for this class of compounds. Pharmacological characterization of all the compounds at G-, G- and G-mediated signalling provided succinct information on the structural requirements for inhibition, and demonstrated that both YM-254890 and FR900359 are highly potent inhibitors of G signalling, with FR900359 being the most potent. These natural products and their analogues represent unique tools for explorative studies of G protein inhibition.

摘要

G 蛋白是 G 蛋白偶联受体信号转导的关键介质,它促进了许多重要的生理过程。环二肽 YM-254890 和 FR900359 是已知的 G 蛋白亚家族的特异性抑制剂;然而,以前没有报道过这些复杂天然产物的合成路线,而且它们也不容易从天然来源中分离出来。在这里,我们首次报道了 YM-254890 和 FR900359 的全合成,以及两种已知类似物 YM-385780 和 YM-385781 的全合成。该合成方法的多功能性还使设计和合成了十种类似物成为可能,这为该类化合物进行了首次的构效关系研究。所有化合物在 G-、G-和 G-介导的信号转导中的药理学特性提供了抑制的结构要求的简洁信息,并证明 YM-254890 和 FR900359 都是 G 信号转导的高效抑制剂,FR900359 的抑制活性最强。这些天然产物及其类似物代表了探索性研究 G 蛋白抑制的独特工具。

相似文献

1
Total synthesis and structure-activity relationship studies of a series of selective G protein inhibitors.一系列选择性 G 蛋白抑制剂的全合成及构效关系研究。
Nat Chem. 2016 Nov;8(11):1035-1041. doi: 10.1038/nchem.2577. Epub 2016 Jul 25.
2
Structure-Activity Relationship Studies of the Natural Product G Protein Inhibitor YM-254890.天然产物 G 蛋白抑制剂 YM-254890 的构效关系研究。
ChemMedChem. 2019 Apr 17;14(8):865-870. doi: 10.1002/cmdc.201900018. Epub 2019 Mar 21.
3
Structure-Activity Relationship Studies of the Cyclic Depsipeptide Natural Product YM-254890, Targeting the G Protein.靶向G蛋白的环缩肽天然产物YM-254890的构效关系研究
ChemMedChem. 2017 Jun 7;12(11):830-834. doi: 10.1002/cmdc.201700155. Epub 2017 May 16.
4
Deciphering Specificity Determinants for FR900359-Derived G α Inhibitors Based on Computational and Structure-Activity Studies.基于计算和结构活性研究解析 FR900359 衍生的 Gα 抑制剂的特异性决定因素。
ChemMedChem. 2018 Aug 20;13(16):1634-1643. doi: 10.1002/cmdc.201800304. Epub 2018 Jul 3.
5
Structure-activity relationship and conformational studies of the natural product cyclic depsipeptides YM-254890 and FR900359.天然产物环二肽 YM-254890 和 FR900359 的构效关系和构象研究。
Eur J Med Chem. 2018 Aug 5;156:847-860. doi: 10.1016/j.ejmech.2018.07.023. Epub 2018 Jul 12.
6
Delineation of molecular determinants for FR900359 inhibition of G unlocks inhibition of Gα.明确 FR900359 抑制 G 蛋白的分子决定因素,揭示其对 Gα 的抑制作用。
J Biol Chem. 2020 Oct 2;295(40):13850-13861. doi: 10.1074/jbc.RA120.013002. Epub 2020 Aug 4.
7
Rational design of a heterotrimeric G protein α subunit with artificial inhibitor sensitivity.具有人工抑制剂敏感性的异三聚体 G 蛋白 α 亚基的合理设计。
J Biol Chem. 2019 Apr 12;294(15):5747-5758. doi: 10.1074/jbc.RA118.007250. Epub 2019 Feb 11.
8
An experimental strategy to probe Gq contribution to signal transduction in living cells.一种在活细胞中探测 Gq 对信号转导贡献的实验策略。
J Biol Chem. 2021 Jan-Jun;296:100472. doi: 10.1016/j.jbc.2021.100472. Epub 2021 Feb 25.
9
In Vitro Module Editing Of NRPS Enables Production Of Highly Potent G -Signaling Inhibitor FR900359 Derived From Unculturable Plant Symbiont.在体模块编辑 NRPS 使来源于不可培养植物共生体的强效 G 信号抑制剂 FR900359 的生产成为可能。
Angew Chem Int Ed Engl. 2024 Mar 4;63(10):e202317805. doi: 10.1002/anie.202317805. Epub 2024 Feb 2.
10
Recent achievements in developing selective G inhibitors.开发选择性G抑制剂的最新成果。
Med Res Rev. 2020 Jan;40(1):135-157. doi: 10.1002/med.21598. Epub 2019 Jun 19.

引用本文的文献

1
Design, Synthesis, and Antitumor Biological Evaluation of Galaxamide and Its Analogs.海石酰胺及其类似物的设计、合成与抗肿瘤生物学评价
Molecules. 2025 May 29;30(11):2362. doi: 10.3390/molecules30112362.
2
Cyclic peptide inhibitors function as molecular glues to stabilize Gq/11 heterotrimers.环肽抑制剂作为分子胶起作用,以稳定Gq/11异源三聚体。
Proc Natl Acad Sci U S A. 2025 May 13;122(19):e2418398122. doi: 10.1073/pnas.2418398122. Epub 2025 May 7.
3
Stabilization of interdomain closure by a G protein inhibitor.通过 G 蛋白抑制剂稳定结构域关闭。

本文引用的文献

1
Structure, Function, Pharmacology, and Therapeutic Potential of the G Protein, Gα/q,11.G 蛋白、Gα/q、11 的结构、功能、药理学和治疗潜力。
Front Cardiovasc Med. 2015 Mar 24;2:14. doi: 10.3389/fcvm.2015.00014. eCollection 2015.
2
The experimental power of FR900359 to study Gq-regulated biological processes.FR900359用于研究Gq调节的生物过程的实验效能。
Nat Commun. 2015 Dec 14;6:10156. doi: 10.1038/ncomms10156.
3
Emerging Approaches to GPCR Ligand Screening for Drug Discovery.新兴的 G 蛋白偶联受体配体筛选方法及其在药物发现中的应用。
Proc Natl Acad Sci U S A. 2024 Sep 3;121(36):e2311711121. doi: 10.1073/pnas.2311711121. Epub 2024 Aug 28.
4
A neurodevelopmental disorder mutation locks G proteins in the transitory pre-activated state.一种神经发育障碍突变将 G 蛋白锁定在短暂的预激活状态。
Nat Commun. 2024 Aug 5;15(1):6643. doi: 10.1038/s41467-024-50964-z.
5
A Building Block Approach for the Total Synthesis of YM-385781.一种用于全合成YM-385781的模块法。
European J Org Chem. 2023 May 22;26(20). doi: 10.1002/ejoc.202300365. Epub 2023 Apr 25.
6
Recommended Tool Compounds: Application of YM-254890 and FR900359 to Interrogate Gα-Mediated Signaling Pathways.推荐的工具化合物:应用YM-254890和FR900359探究Gα介导的信号通路。
ACS Pharmacol Transl Sci. 2023 Nov 10;6(12):1790-1800. doi: 10.1021/acsptsci.3c00214. eCollection 2023 Dec 8.
7
Bicyclic Peptide Library Screening for the Identification of Gαi Protein Modulators.双环肽文库筛选鉴定 Gαi 蛋白调节剂。
J Med Chem. 2023 Sep 14;66(17):12396-12406. doi: 10.1021/acs.jmedchem.3c00873. Epub 2023 Aug 16.
8
The Bacterial G Signal Transduction Inhibitor FR900359 Impairs Soil-Associated Nematodes.细菌 G 信号转导抑制剂 FR900359 可损害土壤相关线虫。
J Chem Ecol. 2023 Oct;49(9-10):549-569. doi: 10.1007/s10886-023-01442-1. Epub 2023 Jul 15.
9
Structure-affinity and structure-residence time relationships of macrocyclic Gα protein inhibitors.大环Gα蛋白抑制剂的结构-亲和力和结构-驻留时间关系
iScience. 2023 Mar 23;26(4):106492. doi: 10.1016/j.isci.2023.106492. eCollection 2023 Apr 21.
10
Catalytic site mutations confer multiple states of G protein activation.催化位点突变赋予 G 蛋白多种激活状态。
Sci Signal. 2023 Feb 14;16(772):eabq7842. doi: 10.1126/scisignal.abq7842.
Trends Mol Med. 2015 Nov;21(11):687-701. doi: 10.1016/j.molmed.2015.09.002. Epub 2015 Oct 16.
4
Toward the Selective Inhibition of G Proteins: Total Synthesis of a Simplified YM-254890 Analog.针对 G 蛋白的选择性抑制:简化版 YM-254890 类似物的全合成。
Org Lett. 2015 May 1;17(9):2270-3. doi: 10.1021/acs.orglett.5b00944. Epub 2015 Apr 15.
5
Characterization of UBO-QIC as a Gαq inhibitor in platelets.血小板中UBO-QIC作为Gαq抑制剂的特性研究。
Platelets. 2015;26(8):771-8. doi: 10.3109/09537104.2014.998993. Epub 2015 Mar 3.
6
Total synthesis of the cyclic depsipeptide YM-280193, a platelet aggregation inhibitor.环状缩肽 YM-280193 的全合成,一种血小板聚集抑制剂。
Org Lett. 2015 Feb 6;17(3):492-5. doi: 10.1021/ol503507g. Epub 2015 Jan 15.
7
Recent developments in biased agonism.最近在偏向激动剂方面的进展。
Curr Opin Cell Biol. 2014 Apr;27:18-24. doi: 10.1016/j.ceb.2013.10.008. Epub 2013 Nov 20.
8
Biasing GPCR signaling from inside.从内部调控G蛋白偶联受体信号传导
Sci Signal. 2014 Jan 28;7(310):pe3. doi: 10.1126/scisignal.2005021.
9
The first total synthesis of the cyclodepsipeptide pipecolidepsin A.环二肽哌可啉 A 的全合成。
Nat Commun. 2013;4:2352. doi: 10.1038/ncomms3352.
10
The emerging mutational landscape of G proteins and G-protein-coupled receptors in cancer.癌症中 G 蛋白和 G 蛋白偶联受体的新兴突变景观。
Nat Rev Cancer. 2013 Jun;13(6):412-24. doi: 10.1038/nrc3521. Epub 2013 May 3.